Ono Pharmaceutical Co., Ltd. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 447,187 million. Basic earnings per share from continuing operations was JPY 230.85.

Diluted earnings per share from continuing operations was JPY 230.79.